1
CARDIOVASCULAR
hamburger

Abbott offers access devices that help electrophysiologists and cardiac interventionalists reliably access areas of the heart during ablation and mapping procedures. We design our devices to deliver high maneuverability and enhanced physician control1,2 even during complex electrophysiology (EP) procedures.

Agilis NxT Steerable Introducer

The Agilis™ NxT steerable introducer is designed to replace a fixed curve introducer. It helps you reach hard-to-access areas of the heart by providing a stable platform for improved catheter manipulation and contact. Used in more than 1,000,000 procedures, the Agilis NxT steerable introducer provides outstanding agility and stability during catheter access and positioning.2

  • Manuals & Technical Resources
  • Cardiovascular Products
  • Customer Service

References

  1. Piorkowski, C., Kottkamp, H., Gerds-Li, J. H., Arya, A., Sommers, P., Dagres, N., Hindricks, G. (2008). Steerable sheath catheter navigation for ablation of atrial fibrillation: A case-control study. Pacing and Clinical Electrophysiology, 31(7), 863-873. http://dx.doi.org/10.1111/j.1540-8159.2008.01101.x
  2. Abbott Data on file, Agilis NxT Steerable Introducer Claims Matrix, Document # 90119641. World's leading steerable introducer claim based on IMS EP Q1 18 Market Share data.

Indications, Safety & Warnings

Agilis™ NxT Steerable Introducer, all models except for 40cm

Indications: The Agilis™ NxT Steerable Introducer is indicated when introducing various cardiovascular catheters into the heart, including the left side of the heart through the interatrial septum.

Contraindications: The Agilis™ NxT Steerable Introducer is contraindicated for previous intra-atrial septal patch, Known or suspected atrial myxoma, Myocardial Infarctions within the last two weeks, Unstable angina, Recent Cerebral Vascular Accident (CVA), Patients who do not tolerate anticoagulation therapy, Patients with an active infection, and Presence of atrial thrombus.

Warnings: Do not alter this device in any way. Only those physicians who are trained in transseptal procedures and Abbott delivery systems should use this device. Do Not reuse this device. Thorough cleaning of biological and foreign material is not possible. Adverse patient reactions may result from reuse of this device. Maintain continuous hemodynamic monitoring throughout procedure. Always observe acceptable hemodynamics prior to advancing the dilator or any other component. Always withdraw components/aspirate slowly to minimize the vacuum created during withdrawal. From the sideport only – aspirate all air prior to fluid infusion. Provide continuous heparinized saline infusion while the introducer remains in the vessel. Fibrin may accumulate in or on the sheath tip during the procedure. To prevent dislodgment of potential thrombus, aspirate when removing dilator or catheter. Prior to removing the steerable introducer, reinsert the guidewire through the introducer, reintroduce the dilator over the guidewire, straighten the steerable introducer, then remove the dilator, guidewire, and introducer as a unit. Maximum in-vivo time: 7 hours.

Precautions:  US federal law restricts this device to sale by or on the order of a physician. Carefully read instructions before use of device to help reduce potential risks and complications associated with transseptal procedures, such as air emboli and/or perforation of the aorta and left atrium (LA). (Perforation of the aorta and LA not included for 82 cm device). Inspect all components before use. Do not use if package or items in kit appear to be damaged or defective. The French size specified represents the inner diameter of the introducer sheath.

Potential adverse events:  Cardiac perforation, Embolus, Cerebrovascular accident, Death, Atrial fibrillation, Dissection and Heart block.

Agilis™ NxT Steerable Introducer, 40cm

Indications: The Agilis™ NxT Steerable Introducer is indicated when introducing various cardiovascular catheters into the heart.

Contraindications: The Agilis™ NxT Steerable Introducer is contraindicated for known or suspected atrial myxoma, Myocardial Infarctions within the last two weeks, Unstable angina, Recent Cerebral Vascular Accident (CVA), Patients who do not tolerate anticoagulation therapy, Patients with an active infection and Presence of atrial thrombus.

Warnings: Do not alter this device in any way. Only those physicians who are trained in transseptal procedures and Abbott delivery systems should use this device. Do Not reuse this device. Thorough cleaning of biological and foreign material is not possible. Adverse patient reactions may result from reuse of this device. Maintain continuous hemodynamic monitoring throughout procedure. Always observe acceptable hemodynamics prior to advancing the dilator or any other component.

Precautions:  US federal law restricts this device to sale by or on the order of a physician. Carefully read instructions before use of device to help reduce potential risks and complications associated with transseptal procedures, such as air emboli and/or perforation of the aorta and left atrium (LA). (Perforation of the aorta and LA not included for 82 cm device). Inspect all components before use. Do not use if package or items in kit appear to be damaged or defective. The French size specified represents the inner diameter of the introducer sheath.

Potential adverse events:   Cardiac perforation, Embolus, Cerebrovascular accident, Death, Atrial fibrillation, Dissection and Heart block.

Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.

MAT-2006882 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2019 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.